Punicalagin, (mixture of α+β) - 98% min

CAS : 65995-63-3

Ref. 3D-FP74904

Informations sur le produit

• Nom: Punicalagin, (mixture of α+β) - 98% min
• Synonymes: 1,2,3,11,12,13-Hexahydroxy-5,10-Dioxo-8-[3,4,5,11,17,18,19,22,23,34,35-Undecahydroxy-8,14,26,31-Tetraoxo-9,13,25,32-Tetraoxaheptacyclo[25.8.0.02,7.015,20.021,30.024,29.028,33]Pentatriaconta-1(35),2,4,6,15,17,19,21,23,27,29,33-Dodecaen-10-Yl]-5,7,8,10-Tetrahydrodibenzo[F,H][1,4]Dioxecine-7-Carbaldehyde (Non-Preferred Name), 2,20,1,23-(Epoxy[2]propene[1,2]diyl[3]ylidene)-11H,15H-tribenzo[g,i,q][1,5,12]trioxacyclononadecin, <span class="text-smallcaps">D</span>-glucose deriv., <span class="text-smallcaps">D</span>-Glucose, cyclic 4,6-[(2S,2′S)-2,2′-(5,10-dihydro-2,3,7,8-tetrahydroxy-5,10-dioxo[1]benzopyrano[5,4,3-cde][1]benzopyran-1,6-diyl)bis[3,4,5-trihydroxybenzoate]] cyclic 2,3-[(1S)-4,4′,5,5′,6,6′-hexahydroxy[1,1′-biphenyl]-2,2′-dicarboxylate], <span class="text-smallcaps">D</span>-Glucose, cyclic 4,6-[(S,S)-2,2′-(5,10-dihydro-2,3,7,8-tetrahydroxy-5,10-dioxo[1]benzopyrano[5,4,3-cde][1]benzopyran-1,6-diyl)bis[3,4,5-trihydroxybenzoate]] cyclic 2,3-[(S)-4,4′,5,5′,6,6′-hexahydroxy[1,1′-biphenyl]-2,2′-dicarboxylate], <span class="text-smallcaps">D</span>-Glucose, cyclic 4,6-[2,2′-(5,10-dihydro-2,3,7,8-tetrahydroxy-5,10-dioxo[1]benzopyrano[5,4,3-cde][1]benzopyran-1,6-diyl)bis[3,4,5-trihydroxybenzoate]] cyclic 2,3-(4,4′,5,5′,6,6′-hexahydroxy[1,1′-biphenyl]-2,2′-dicarboxylate), [2(S),4(S,S)]-, D-Glucose, cyclic 4,6-(2,2'-(5,10-dihydro-2,3,7,8-tetrahydroxy-5,10-dioxo(1)benzopyrano(5,4,3-cde)(1)benzopyran-1,6-diyl)bis(3,4,5-trihydroxybenzoate)) cyclic 2,3-(4,4',5,5',6,6'-hexahydroxy(1,1'-biphenyl)-2,2'-dicarboxylate)-, (2(S),4(S,S))-, Dibenzo[f,h][1,4]dioxecin, <span class="text-smallcaps">D</span>-glucose deriv., Pomegranate extract, Punicalagins
• CAS: 65995-63-3

Description

Punicalagin is a mixture of α+β-punicalagins, which are ellagitannins from the pomegranate fruit. It is a powerful inhibitor of bacterial growth and has been shown to reduce the expression of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α) in human monocytes. Punicalagin also has immunosuppressive activities and may be useful for cancer therapy. This compound inhibits the production of inflammatory cytokines by inhibiting the activation of nuclear factor kappa B and protein kinase Cδ. In addition, punicalagin enhances autophagy in human colon cancer cells by upregulating the expression of genes that promote this process.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 1,084.72 g/mol
• Formule: C₄₈H₂₈O₃₀
• Degré de pureté: Min. 98 Area-%
• Couleur/Forme: Off-White Powder